Receive the latest alerts via email

New Valuation: Regeneron Pharmaceuticals Inc (REGN)

Regeneron Pharmaceuticals Inc (NASDAQ:REGN) 
(fair value)

Website https://www.regeneron.com
Sector Health Care
Industry Biotechnology
Fiscal Year End December
Market Cap $82B
Beta 0.24
Dividends per share $0.00
Current Price $736.33
Autochartist™ Valuation $754.00
Conclusion
(fair value)

Download PDF Report

Total
0
Shares
Previous Post

New Valuation: Dow Inc (DOW)

Next Post

New Valuation: Take-Two Interactive Software Inc (TTWO)

Related Posts